Both methods were used to generate human mAbs against peanut 2S albumins, major allergens in peanut allergy, and anti-Rho guanosine diphosphate dissociation inhibitor 2 (RhoGDI2, alternative and used ‘ARHGDIB’), a non-HLA target potentially involved in graft failure upon kidney transplantation (19). The gene discussed is ARHGDIB; the disease is peanut allergic reaction.